These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1071390)

  • 21. Effects of THC on behavioral measures of impulsivity in humans.
    McDonald J; Schleifer L; Richards JB; de Wit H
    Neuropsychopharmacology; 2003 Jul; 28(7):1356-65. PubMed ID: 12784123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Time profile of serum THC levels in occasional and chronic marihuana smokers after acute drog use - implication for drivind motor vehicles].
    Balíková M; Hložek T; Páleníček T; Tylš F; Viktorinová M; Melicher T; Androvičová R; Tomíček P; Roman M; Horáček J
    Soud Lek; 2014; 59(1):2-6. PubMed ID: 24625019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of delta 9-THC on marijuana smoking, dose choice, and verbal report of drug liking.
    Kelly TH; Foltin RW; Emurian CS; Fischman MW
    J Exp Anal Behav; 1994 Mar; 61(2):203-11. PubMed ID: 8169569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration.
    Schlienz NJ; Lee DC; Stitzer ML; Vandrey R
    Drug Alcohol Depend; 2018 Jun; 187():254-260. PubMed ID: 29689485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of delta 9-THC on human platelet phospholipids.
    Kalofoutis A; Lekakis J; Koutselinis A
    Pharmacol Biochem Behav; 1980 May; 12(5):697-9. PubMed ID: 6248897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral and electroencephalographic correlates of the chronic use of marijuana--a review.
    Fried PA
    Behav Biol; 1977 Oct; 21(2):163-96. PubMed ID: 334157
    [No Abstract]   [Full Text] [Related]  

  • 27. Δ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans.
    Cortes-Briones J; Skosnik PD; Mathalon D; Cahill J; Pittman B; Williams A; Sewell RA; Ranganathan M; Roach B; Ford J; D'Souza DC
    Neuropsychopharmacology; 2015 Aug; 40(9):2124-34. PubMed ID: 25709097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
    Oviedo A; Glowa J; Herkenham M
    Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of high dosage delta-9-tetrahydrocannabinol on sleep patterns in man.
    Feinberg I; Jones R; Walker JM; Cavness C; March J
    Clin Pharmacol Ther; 1975 Apr; 17(4):458-66. PubMed ID: 164314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolerance to delta9-tetrahydrocannabinol in adapted and nonadapted rabbits.
    Martin P; Consroe P
    Pharmacol Biochem Behav; 1978 Dec; 9(6):753-8. PubMed ID: 746051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabis use and the development of tolerance: a systematic review of human evidence.
    Colizzi M; Bhattacharyya S
    Neurosci Biobehav Rev; 2018 Oct; 93():1-25. PubMed ID: 30056176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced responsiveness of the reward system is associated with tolerance to cannabis impairment in chronic users.
    Mason NL; Theunissen EL; Hutten NRPW; Tse DHY; Toennes SW; Jansen JFA; Stiers P; Ramaekers JG
    Addict Biol; 2021 Jan; 26(1):e12870. PubMed ID: 31865628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical studies of cannabis tolerance and dependence.
    Jones RT; Benowitz N; Bachman J
    Ann N Y Acad Sci; 1976; 282():221-39. PubMed ID: 798533
    [No Abstract]   [Full Text] [Related]  

  • 34. Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans.
    D'Souza DC; Pittman B; Perry E; Simen A
    Psychopharmacology (Berl); 2009 Mar; 202(4):569-78. PubMed ID: 18807247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Divided attention performance of cannabis users and non-users following cannabis and alcohol.
    Macavoy MG; Marks DF
    Psychopharmacologia; 1975 Oct; 44(2):147-52. PubMed ID: 1105631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15.
    Niesink RJ; Rigter S; Koeter MW; Brunt TM
    Addiction; 2015 Dec; 110(12):1941-50. PubMed ID: 26234170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis.
    Khiabani HZ; Mørland J; Bramness JG
    Eur J Intern Med; 2008 Dec; 19(8):608-12. PubMed ID: 19046727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute marihuana (THC) exposure produces a "transient" topographic quantitative EEG profile identical to the "persistent" profile seen in chronic heavy users.
    Struve FA; Manno BR; Kemp P; Patrick G; Manno JE
    Clin Electroencephalogr; 2003 Apr; 34(2):75-83. PubMed ID: 12784905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlations between cannabis-induced psychopathology and EEG before and after drug ingestion.
    Koukkou M; Lehmann D
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Sep; 11(5):220-7. PubMed ID: 704663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hashish extract impairs retention of defeat-induced submissive behavior in mice.
    Frischknecht HR; Siegfried B; Schiller M; Waser PG
    Psychopharmacology (Berl); 1985; 86(3):270-3. PubMed ID: 2994143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.